FURIEX PHARMACEUTICALS, INC. Stock-Based Compensation
FURIEX PHARMACEUTICALS, INC. reported Stock-Based Compensation of $2.40 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2014-05-09
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $2.40M, a 2.68% decline year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2013-12-31 was $1.34M, a 1.18% decline year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2013-09-30 was $1.50M, a 25.00% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2013-06-30 was $1.60M, a 23.08% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2013 was $6.90M, a 24.61% increase from fiscal 2012.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2012 was $5.54M, a 32.51% increase from fiscal 2011.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2011 was $4.18M, a 4080.00% increase from fiscal 2010.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2010 was $100.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2014-03-31 | $2.40M 10-Q · filed 2014-05-09 | $3.73M derived: sum of 2 quarters · filed 2014-05-09 | $5.24M derived: sum of 3 quarters · filed 2014-05-09 | $6.83M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.84M derived: sum of 2 quarters · filed 2014-03-17 | $4.44M derived: sum of 3 quarters · filed 2014-03-17 | $6.90M 10-K · filed 2014-03-17 |
| 2013-09-30 | $1.50M 10-Q · filed 2013-11-12 | $3.10M derived: sum of 2 quarters · filed 2013-11-12 | $5.56M 10-Q · filed 2013-11-12 | $6.92M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | $1.60M 10-Q · filed 2013-08-08 | $4.02M 10-Q · filed 2013-08-08 | $5.42M derived: sum of 3 quarters · filed 2014-05-09 | $6.62M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-03-31 | $2.46M 10-Q · filed 2014-05-09 | $3.82M derived: sum of 2 quarters · filed 2014-05-09 | $5.02M derived: sum of 3 quarters · filed 2014-05-09 | $6.32M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.55M derived: sum of 2 quarters · filed 2014-03-17 | $3.85M derived: sum of 3 quarters · filed 2014-03-17 | $5.54M 10-K · filed 2014-03-17 |
| 2012-09-30 | $1.20M 10-Q · filed 2013-11-12 | $2.50M derived: sum of 2 quarters · filed 2013-11-12 | $4.18M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $1.30M 10-Q · filed 2013-08-08 | $2.94M 10-Q · filed 2013-08-08 | ||
| 2011-12-31 | $4.18M 10-K · filed 2014-03-17 | |||
| 2010-12-31 | $100.00K 10-K · filed 2013-03-18 |